Development of a Series of Tanshinone Derivatives Through Scaffold Hopping for Treating Non-Small-Cell Lung Cancer (NSCLC). [PDF]
Zhou LX +8 more
europepmc +1 more source
Therapeutic Potential of <i>Salvia miltiorrhiza</i> in Glioblastoma: Evidence from in vitro and in vivo Studies. [PDF]
Lee CC +10 more
europepmc +1 more source
Dihydrotanshinone as a Natural Product-Based CYP17A1 Lyase Inhibitor for Hyperandrogenic Disorders. [PDF]
Li K +3 more
europepmc +1 more source
Long-term efficacy of the <i>Astragalus-Salvia miltiorrhiza</i> botanical drug pair in stable coronary artery disease and a nomogram for predicting frequent hospitalization: a real-world retrospective cohort study. [PDF]
Fu L, Han J, Gao Z, Long H, Liu Y, Li Y.
europepmc +1 more source
Tanshinone IIA restores CD8<sup>+</sup> T-cell immunity in TNBC by suppressing the IDO1-kynurenine axis. [PDF]
Qiu Z, Meng C, Tang M.
europepmc +1 more source
Phytochemical Monomers Derived from Traditional Chinese Medicine May Prevent and Treat Atherosclerosis by Modulating the Macrophage Mitochondrial-Lysosomal Senescence Axis. [PDF]
Zhao H +6 more
europepmc +1 more source
Characterization and functional analysis of miRNAs in Salvia miltiorrhiza-isolated exosome-like nanoparticles for gastric cancer treatment. [PDF]
Chen G, Zhong Q, Tang N.
europepmc +1 more source
Pharmacological effects of <i>Salvia miltiorrhiza-</i>derived interventions on osteoporosis in animal models: a systematic review and meta-analysis. [PDF]
Zhang Y +8 more
europepmc +1 more source
Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis. [PDF]
Lv H, Yang X, Liu Y, Zhou J, Yu W.
europepmc +1 more source

